162 related articles for article (PubMed ID: 30482874)
1. Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis.
Amirian ES; Ostrom QT; Armstrong GN; Lai RK; Gu X; Jacobs DI; Jalali A; Claus EB; Barnholtz-Sloan JS; Il'yasova D; Schildkraut JM; Ali-Osman F; Sadetzki S; Jenkins RB; Lachance DH; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Johansen C; Houlston RS; Scheurer ME; Shete S; Amos CI; Melin B; Bondy ML
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):555-562. PubMed ID: 30482874
[TBL] [Abstract][Full Text] [Related]
2. Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case-control study.
Gaist D; García-Rodríguez LA; Sørensen HT; Hallas J; Friis S
Br J Cancer; 2013 Mar; 108(5):1189-94. PubMed ID: 23449355
[TBL] [Abstract][Full Text] [Related]
3. Analgesic use and the risk of primary adult brain tumor.
Egan KM; Nabors LB; Thompson ZJ; Rozmeski CM; Anic GA; Olson JJ; LaRocca RV; Chowdhary SA; Forsyth PA; Thompson RC
Eur J Epidemiol; 2016 Sep; 31(9):917-25. PubMed ID: 26894804
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort.
Daugherty SE; Moore SC; Pfeiffer RM; Inskip PD; Park Y; Hollenbeck A; Rajaraman P
Cancer Prev Res (Phila); 2011 Dec; 4(12):2027-34. PubMed ID: 21885814
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink.
Bannon FJ; O'Rorke MA; Murray LJ; Hughes CM; Gavin AT; Fleming SJ; Cardwell CR
Cancer Causes Control; 2013 Nov; 24(11):2027-34. PubMed ID: 23990380
[TBL] [Abstract][Full Text] [Related]
6. HMG CoA reductase inhibitors, NSAIDs and risk of glioma.
Ferris JS; McCoy L; Neugut AI; Wrensch M; Lai R
Int J Cancer; 2012 Sep; 131(6):E1031-7. PubMed ID: 22419506
[TBL] [Abstract][Full Text] [Related]
7. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
Din FV; Theodoratou E; Farrington SM; Tenesa A; Barnetson RA; Cetnarskyj R; Stark L; Porteous ME; Campbell H; Dunlop MG
Gut; 2010 Dec; 59(12):1670-9. PubMed ID: 20844293
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
9. Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma.
Seliger C; Meier CR; Becker C; Jick SS; Bogdahn U; Hau P; Leitzmann MF
PLoS One; 2016; 11(2):e0149293. PubMed ID: 26871579
[TBL] [Abstract][Full Text] [Related]
10. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
11. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.
Hurwitz LM; Joshu CE; Barber JR; Prizment AE; Vitolins MZ; Jones MR; Folsom AR; Han M; Platz EA
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):563-569. PubMed ID: 30487131
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
14. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
Trabert B; Ness RB; Lo-Ciganic WH; Murphy MA; Goode EL; Poole EM; Brinton LA; Webb PM; Nagle CM; Jordan SJ; ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Lurie G; Kjær SK; Hogdall E; Jensen A; Cramer DW; Terry KL; Vitonis A; Bandera EV; Olson S; King MG; Chandran U; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike MC; Berchuck A; Schildkraut JM; Wentzensen N;
J Natl Cancer Inst; 2014 Feb; 106(2):djt431. PubMed ID: 24503200
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies.
Verdoodt F; Friis S; Dehlendorff C; Albieri V; Kjaer SK
Gynecol Oncol; 2016 Feb; 140(2):352-8. PubMed ID: 26701413
[TBL] [Abstract][Full Text] [Related]
16. Aspirin Use and Risk of Glioma: a Double Track for a Single Goal?
Mormile R
Pathol Oncol Res; 2020 Apr; 26(2):1363-1364. PubMed ID: 31332695
[No Abstract] [Full Text] [Related]
17. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
Veitonmäki T; Tammela TL; Auvinen A; Murtola TJ
Eur J Cancer; 2013 Mar; 49(4):938-45. PubMed ID: 23079475
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
[TBL] [Abstract][Full Text] [Related]
19. Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis.
Neill AS; Nagle CM; Protani MM; Obermair A; Spurdle AB; Webb PM;
Int J Cancer; 2013 Mar; 132(5):1146-55. PubMed ID: 22777678
[TBL] [Abstract][Full Text] [Related]
20. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Tawfik H; Teitelbaum SL; Britton JA; Subbaramaiah K; Dannenberg AJ; Neugut AI
JAMA; 2004 May; 291(20):2433-40. PubMed ID: 15161893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
